← Open Payments lookup

JESSICA BROCK: Open Payments

NPI 1295148914 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$498 in 19 payments from 9 companies in 2025. Trend: 2023 $296 · 2024 $806 · 2025 $498

Food & beverage: $498
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc2$164
Neurocrine BioSciences, Inc.4$73
Vanda Pharmaceuticals Inc.3$72
Axsome Therapeutics, Inc.3$61
ABBVIE INC.3$49
Otsuka America Pharmaceutical, Inc.1$24
Lundbeck LLC1$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17
E.R. Squibb & Sons, L.L.C.1$15

Products named: INVEGA SUSTENNA, INGREZZA, Auvelity, FANAPT, VRAYLAR, REXULTI, HETLIOZ, CAPLYTA.

Industry payments across KY — which companies pay providers there.